Narrative review / 2015
Short-term microbiome interventions may only have transient effects in inflammatory bowel disease as the adult microbiome tends to revert post-treatment.
Inflammatory bowel disease encompasses chronic conditions driven by excessive gastrointestinal inflammation, with the gut microbiome playing a critical role in its pathogenesis. This review examined therapies aimed at manipulating the microbiome, including diet, pre- and probiotics, antibiotics, and fecal microbiota transplant. Current literature indicates that the adult microbiome is highly resilient to short-term interventions, triggering rapid changes that typically revert to pre-treatment states once therapy concludes. Consequently, short-term manipulation of the human microbiome may produce only transient therapeutic effects.
- Study type
- Narrative review
- Who was studied
- Patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)
- What was measured
- Alterations to the microflora and duration of impact from interventions
THE PAPER
Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
Berg D, Clemente JC, Colombel JF. Expert Rev Gastroenterol Hepatol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.